Backgrounds/Aims: Surgical resection, such as pancreaticoduodenectomy (PD), is used for treatment of benign periampullary tumors, but high morbidity and mortality resulting from PD can be a huddle. The aim of this study is to suggest a safe and less invasive procedure for treatment of benign periampullary tumors. Methods: From January 2001 to September 2016, 31 patients with ampulla of Vater (AOV) tumors were reviewed retrospectively. Patients who were confirmed with malignancy through biopsy were excluded, except for one patient with malignancy and multiple underlying diseases. To investigate the safety and availability of transduodenal ampullectomy (TDA), TDA and endoscopic papillectomy (EP) were compared. Results: There was no significant difference in the occurrence of complications between the TDA group and EP group (p=0.145), and the resection margins were negative in both groups. There was no recurrence in patients who had TDA, while one patient had a recurrence after EP. Conclusions: This study suggests that TDA is as safe as EP for treating benign periampullary tumors. 
INTRODUCTION
Tumors originating from the ampulla of Vater (AOV) may be either benign neoplasms or malignant. Benign neoplasms are rare, representing less than 10% of periampullary neoplasms. 1 The most common benign lesions are adenomas. 2, 3 Ampullary adenomas may possibly progress to carcinoma. 4 There are three ways to remove periampullary adenomas: pancreaticoduodenectomy (PD), transduodenal ampullectomy (TDA), or endoscopic papillectomy (EP).
Indications for surgical resection are an adenoma greater than 2 cm in diameter, evidence of lymph node involvement, and evidence of ingrowth of adenoma into the bile or pancreatic duct. 5 However, high morbidity and mortality due to aggressive resection remain an issue. Before PD was introduced by Whipple in 1899, Halstead first introduced TDA. However, due to high recurrent rate in AOV cancers, interest in TDA has retreated without much response. 6, 7 Consequently, a less invasive procedure, EP, first described in the late 1980s, 8, 9 has been developed due to high morbidity and mortality associated with surgical resection. Only recently have EP and TDA become common procedures for treatment of benign ampullary tumors.
Since there are no clear guidelines for treatment of periampullary tumors, 10 the purpose of this study was to suggest a safe and minimally invasive method to radically remove AOV tumors by comparing TDA with EP. For patients unable to undergo EP, TDA was conducted as initial treatment. TDA was conducted under two conditions: tumor size greater than 1 cm in diameter; and preoperative biopsy confirming tumor as benign with no evidence of lymph node involvement through image studies. 
MATERIALS AND METHODS

RESULTS
This study is based on a retrospective review of 31 patients that underwent TDA or EP for ampullary tumors.
Of these patients, 16 were diagnosed during routine health checkup without symptoms, except for one patient presented with recurrence. Twelve patients reported abdominal pain, two had jaundice, and one had general weakness (Table 1) . Twenty-one TDAs and 10 EPs were conducted.
There was no significant difference in the total number of complications between the TDA group and EP group (p=0.145). Resection margins were negative in both groups. There was no recurrence in patients with TDA, while one patient experienced recurrence after EP. Four patients that underwent TDA have malignancy even though intraoperative analysis of frozen sections suggested tumors were benign. There were no cases of converted operation from TDA to PD. In the TDA group, nine patients were female and 12 were male, the median patient age was 61 years (range: 35-79), and the median LGD, low grade dysplasia; HGD, high grade dysplasia; AOV, ampulla of Vater tumor size was 1.5 cm (range: 1.0-3.5). In the EP group, three patients were female and seven were male, the median patient age was 64.4 years (range: 52-78), and the median tumor size was 0.8 cm (range: 0.2-1.0) ( Table 2 ).
Postoperative outcomes
There was no significant difference in the total number of complications between the TDA group and EP group (p=0.145). Five cases of complications were observed in the TDA group: one patient that had a transfusion of five packs of red blood cells due to postoperative bleeding, one case of T-tube leakage, two cases of wound infection, and one case of common bile duct stricture. Three cases of bleeding, one case of duodenal ulceration, and one case of duodenal perforation were observed in the EP group.
Median estimated blood loss was 100 ml (range: 50-500) in the TDA group. Duration of hospital stay was longer in the TDA group compared with the EP group (20 vs.
days, respectively). Resection margins were negative
in both groups. One patient experienced recurrence after EP, although the procedure had been conducted in a different institute several years before admission to the present hospital (Table 3) .
Pathology
There were seven cases of low-grade adenoma, one case of hamartoma, and two cases of ectopic pancreatic tissue in the EP group (Table 4 ). In the TDA group, 11 cases LGD, low grade dysplasia of low-grade adenoma, five cases of adenocarcinoma, three cases of adenomatous hyperplasia, one case of high-grade adenoma, and one case of reactive atypia were verified by permanent pathology. One patient diagnosed with adenocarcinoma prior to TDA was previously mentioned above. Accuracy of preoperative biopsy versus final pathological assessment was 81%, and that of intraoperative frozen section versus final pathological results was also 81% (Table 5 ). EP is a less invasive technique, with low morbidity and mortality. 4 Mean length of stay (LOS) in the hospital for EP is comparatively short, a benefit for the patient.
DISCUSSION
Despite advantages, frequent endoscopic checkups are required after EP, and false negative results resulting from inadequate margins may be a drawback. 
